Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Lo Coco

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
Seminars in Oncology|August 12, 2008
Acute promyelocytic leukemia: recent advances in diagnosis and managementFrancesco Lo-Coco, Emanuele Ammatuna, Pau Montesinos, et al.
Current Opinion in Oncology|October 1, 2013
Biology and management of therapy-related acute promyelocytic leukemiaFrancesco Lo-Coco, Syed K Hasan, Pau Montesinos, et al.
Blood Cells, Molecules & Diseases|September 29, 2017
Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulationDomenico Mastrangelo, Elvira Pelosi, Germana Castelli, et al.
Seminars in Hematology|May 16, 2002
Molecular monitoring of hematologic malignancies: current and future issuesFrancesco Lo Coco, Silvia De Santis, Anna Esposito, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 8, 2014
Acute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsAnna Maria Testi, Mariella D'Angiò, Franco Locatelli, et al.
Biochemical Pharmacology|April 28, 2019
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disordersIsabella Faraoni, Manuela Giansanti, Maria Teresa Voso, et al.
Journal of Hematology & Oncology|June 12, 2012
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusIsabella Faraoni, Serena Laterza, Davide Ardiri, et al.
British Journal of Haematology|February 22, 2011
Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutationsRoberta Riccioni, Elvira Pelosi, Viviana Riti, et al.
Haematologica|September 5, 2007
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemiaMassimo Breccia, Giuseppe Cimino, Daniela Diverio, et al.
Leukemia|July 21, 2018
Molecular remission as a therapeutic objective in acute promyelocytic leukemiaLaura Cicconi, Pierre Fenaux, Hagop Kantarjian, et al.
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Seminars in Oncology|August 12, 2008
Acute promyelocytic leukemia: recent advances in diagnosis and managementFrancesco Lo-Coco, Emanuele Ammatuna, Pau Montesinos, et al.
Current Opinion in Oncology|October 1, 2013
Biology and management of therapy-related acute promyelocytic leukemiaFrancesco Lo-Coco, Syed K Hasan, Pau Montesinos, et al.
Blood Cells, Molecules & Diseases|September 29, 2017
Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulationDomenico Mastrangelo, Elvira Pelosi, Germana Castelli, et al.
Seminars in Hematology|May 16, 2002
Molecular monitoring of hematologic malignancies: current and future issuesFrancesco Lo Coco, Silvia De Santis, Anna Esposito, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 8, 2014
Acute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsAnna Maria Testi, Mariella D'Angiò, Franco Locatelli, et al.
Biochemical Pharmacology|April 28, 2019
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disordersIsabella Faraoni, Manuela Giansanti, Maria Teresa Voso, et al.
Journal of Hematology & Oncology|June 12, 2012
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusIsabella Faraoni, Serena Laterza, Davide Ardiri, et al.
British Journal of Haematology|February 22, 2011
Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutationsRoberta Riccioni, Elvira Pelosi, Viviana Riti, et al.
Haematologica|September 5, 2007
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemiaMassimo Breccia, Giuseppe Cimino, Daniela Diverio, et al.
Leukemia|July 21, 2018
Molecular remission as a therapeutic objective in acute promyelocytic leukemiaLaura Cicconi, Pierre Fenaux, Hagop Kantarjian, et al.
Pageof 21